Skip to main
BEAM
BEAM logo

Beam Therapeutics (BEAM)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Beam Therapeutics (BEAM) Stock

About Beam Therapeutics (BEAM)

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headqu...read more
Market cap$1.71B
Today's volume314.37K
Revenue (TTM)$63.58M
Avg. daily volume2.27M
EBITDA (TTM)-$408.7M
Open$16.85
Price / earnings ratio-3.69x
Today's range$16.59 - $17.3
Debt / equity14.08x
52 week range$13.53 - $35.25
5 year debt / equity23.51x
Beta (LTM)1.77x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio8.81x
Ex-dividend date
Next earningsAug 5, 2025
Dividend payable date

Beam Therapeutics Stock Rating

What analysts recommend for BEAM stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 25%
Buy 42%
Hold 29%
Sell 4%
Strong Sell 0%

Beam Therapeutics Stock News

View all

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for BEAM stock is $1.72B

The current P/E ratio for BEAM stock is -3.69

The 52-week high for BEAM stock is $35.25. The current BEAM stock price $undefined is 100.00% below its 52-week high

The 52-week low for BEAM stock is $13.53. The current BEAM stock price $undefined has increased 100.00% from its 52-week low

No, the BEAM stock does not pay dividends to its shareholders

The target price for BEAM stock is $51.31 based on the average of what a group of analyst think BEAM stock could be worth at a future date. This is not a prediction by Public.com

How to buy BEAM stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in BEAM stock

    Navigate to the Explore page. Then, type BEAM into the search bar. When you see BEAM stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased BEAM stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Beam Therapeutics Stock Earnings

The value each BEAM share was expected to gain vs. the value that each BEAM share actually gained.

Beam Therapeutics (BEAM) reported Q1 2025 earnings per share (EPS) of -$1.24, missing estimates of -$1.17 by 5.98%. In the same quarter last year, Beam Therapeutics's earnings per share (EPS) was -$1.21. Beam Therapeutics is expected to release next earnings on 08/05/2025, with an earnings per share (EPS) estimate of -$1.09.

Buy Beam Therapeutics (BEAM) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.